Vanguard VHT ETF: A Look at This Popular Healthcare Investment
Vanguard Health Care ETF (VHT) has established itself as a significant player in the exchange-traded fund (ETF) landscape since its launch on January 26, 2004. Designed to offer investors broad exposure to the Healthcare – Broad segment of the equity market, VHT has garnered substantial interest from both retail and institutional investors. The increasing popularity of passively managed ETFs stems from their attractive combination of low costs, enhanced transparency, operational flexibility, and considerable tax efficiency – all crucial factors for long-term investment strategies. Sector ETFs, like VHT, present a convenient and effective method for gaining diversified, low-risk exposure to specific sectors, and the Healthcare – Broad sector, one of sixteen broad Zacks sectors, is a particularly compelling area of investment. Currently ranked fifth within this sector, VHT’s performance places it amongst the top 31% of Healthcare ETFs.
The fund’s impressive assets under management, exceeding $17.1 billion, underscore its scale and the confidence investors have in its strategy. Vanguard, as the fund’s sponsor, is a reputable financial institution known for its commitment to low-cost, high-quality investment products. VHT’s core objective is to mirror the performance of the MSCI US Investable Market Health Care 25/50 Index, before accounting for any associated fees and operating expenses. This index represents a carefully selected portfolio of U.S. companies operating within the healthcare sector, reflecting a commitment to aligning returns with market benchmarks. The fund’s operational costs are remarkably low, with an annual operating expense ratio of just 0.09%, a significant advantage when considering the long-term implications of investment management fees. Furthermore, the fund distributes a 1.37% 12-month trailing dividend yield, adding another layer of potential return for investors.
A key element in assessing any investment, particularly ETFs, is understanding its holdings. VHT demonstrates a concentrated allocation within the Healthcare sector, with approximately 100% of its portfolio invested in this segment. Examining the top holdings reveals the substantial influence of several key players: Eli Lilly & Co (LLY) accounts for roughly 11.25% of the fund’s assets, followed closely by Abbvie Inc (ABBV) and Unitedhealth Group Inc (UNH). This strategic weighting reflects the fund’s recognition of leaders within the healthcare industry. Throughout the past 52-week trading period, VHT has fluctuated between $236.71 and $296.03, demonstrating a degree of market volatility inherent in the sector. As of December 9, 2025, the fund has delivered notable returns, adding approximately 13.14% year-to-date and achieving a 7.87% gain over the preceding 12 months.
Beyond its straightforward return, VHT’s risk profile provides important context for potential investors. The ETF exhibits a beta of 0.65, indicating a moderate level of tracking relative to the broader market, and a standard deviation of 13.51% for the trailing three-year period, signifying a medium level of risk related to its volatility. With a diverse portfolio comprising approximately 402 holdings, VHT effectively mitigates company-specific risk, offering investors a broader and more resilient investment. Independent analysis further supports VHT’s investment potential. The fund holds a Zacks ETF Rank of 1 (Strong Buy), based on a comprehensive evaluation encompassing expected asset class return, expense ratio, and momentum, among other critical factors.
Investors seeking exposure to the Healthcare ETFs segment of the market should also consider alternative options. Other notable ETFs, such as iShares Global Healthcare ETF (IXJ) and the Health Care Select Sector SPDR ETF (XLV), provide competitive strategies. IXJ tracks the S&P Global 1200 Healthcare Sector Index, while XLV tracks the Health Care Select Sector Index. Notably, IXJ boasts an expense ratio of 0.4%, and XLV charges 0.08% — representing significant cost savings. In conclusion, Vanguard Health Care ETF (VHT) presents a robust and well-managed investment vehicle for those interested in the healthcare sector. To expand your understanding and acquire more detailed insights into this product and the broader universe of ETFs, it’s recommended to utilize resources like the Zacks ETF Center. Interested in high-performing stock recommendations? Download the report "7 Best Stocks for the Next 30 Days" from Zacks Investment Research today.
